Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

VPS53 protein, human

Known as: HCC suppressor 1 protein, human, hepatocellular carcinoma suppressor 1 protein, human, vacuolar protein sorting 53 (S. cerevisiae) protein, human 
 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Vesicular Transport Proteins

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
The β-catenin/TCF-4-LINC01278-miR-1258-Smad2/3 axis promotes hepatocellular carcinoma metastasis
Hepatocellular carcinoma (HCC) metastasis is largely responsible for HCC-associated recurrence and mortality. We aimed to… Expand
  • table 1
  • figure 1
  • figure 3
Review
2018
Review
2018
Molecular Pathogenesis of Nonalcoholic Steatohepatitis- (NASH-) Related Hepatocellular Carcinoma
The proportion of obese or diabetic population has been anticipated to increase in the upcoming decades, which rises the… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
2018
2018
4Mu Decreases CD47 Expression on Hepatic Cancer Stem Cells and Primes a Potent Antitumor T Cell Response Induced by Interleukin-12.
The tumor microenvironment (TME) represents a complex interplay between different cellular components, including tumor cells and… Expand
Highly Cited
2017
Highly Cited
2017
Hepatic cyclooxygenase-2 overexpression induced spontaneous hepatocellular carcinoma formation in mice
Cyclooxygenase (COX)-2 is upregulated in hepatocellular carcinoma (HCC). However, the direct causative effect of COX-2 in… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Review
2017
Review
2017
Non-coding RNA in hepatocellular carcinoma: Mechanisms, biomarkers and therapeutic targets.
The majority of the human genome is not translated into proteins but can be transcribed into RNA. Even though the resulting non… Expand
  • table 1
  • table 2
  • figure 1
  • figure 2
  • figure 3
2017
2017
T Cell-Activating Mesenchymal Stem Cells as a Biotherapeutic for HCC
The outcome for advanced stage hepatocellular carcinoma (HCC) remains poor, highlighting the need for novel therapies… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Highly Cited
2014
Highly Cited
2014
Forkhead box Q1 promotes hepatocellular carcinoma metastasis by transactivating ZEB2 and VersicanV1 expression
Forkhead box Q1 (FoxQ1) is a master regulator of tumor metastasis. However, the molecular mechanism of FoxQ1 in regulating… Expand
Highly Cited
2014
Highly Cited
2014
Downregulation of microRNA‐15b by hepatitis B virus X enhances hepatocellular carcinoma proliferation via fucosyltransferase 2‐induced Globo H expression
Globo H, a cancer‐associated carbohydrate antigen, is highly expressed in various types of cancers. However, the role of Globo H… Expand
2014
2014
Epitope‐optimized alpha‐fetoprotein genetic vaccines prevent carcinogen‐induced murine autochthonous hepatocellular carcinoma
Immunization with effective cancer vaccines can offer a much needed adjuvant therapy to fill the treatment gap after liver… Expand
2014
2014
Growth inhibition of hepatocellular carcinoma tumor endothelial cells by miR-204-3p and underlying mechanism.
AIM To investigate the mechanism by which miR-204-3p inhibits the growth of hepatocellular carcinoma (HCC) tumor endothelial… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE